Find COVID-19 Vaccines Near You: Vaccines.gov (English) Vacunas.gov (Spanish)
Text your zip code to 438829 (GETVAX) in English or 822862 (VACUNA) in Spanish


Reinstatement of Certain Exclusions Previously Extended

Request for Comments Concerning the Reinstatement of Particular Exclusions

Index of 549 Previously Extended Exclusions

Facsimile of Requested Information

Notice of Reinstatement of Certain Exclusions

Notice of Conforming Amendments - October 14, 2022

Notice of Technical Amendments - October 14, 2022

Notice of Extension of Reinstated Product Exclusions - December 21, 2022

Guidance Regarding Products Covered Both in the COVID Exclusion Notices and the Notices Concerning Possible Reinstatement of Previously Extended Exclusions

On August 27, 2021 USTR opened a docket for public comments on the possible extension of the 99 exclusions for COVID-19 response products (86 FR 48280).  On October 5, 2021, USTR announced that it was starting a review to possibly reinstate 549 previously-extended exclusions (86 FR 56345).  Of the 549 exclusions USTR is currently reviewing for possible reinstatement, 80 of the exclusions also appeared on the COVID-19 extension docket, as they were also identified as products needed to combat COVID-19 (85 FR 85831).  The review for the possible extension of COVID exclusions and the review for the possible reinstatement of exclusions are based on different factors and may result in different effective dates.  Accordingly, interested persons that commented on a product pursuant to the notice on extending exclusions for COVID-related products may also wish to submit comments for the product pursuant to the notice on possible reinstatement of China Section 301 exclusions.

For assistance or questions with China Section 301 Exclusions Process, please contact the Section 301 Hotline at (202) 395-5725.